Logo image of NOTV

INOTIV INC (NOTV) Stock Fundamental Analysis

USA - NASDAQ:NOTV - US45783Q1004 - Common Stock

1.37 USD
-0.08 (-5.52%)
Last: 9/19/2025, 8:00:01 PM
1.38 USD
+0.01 (+0.73%)
After Hours: 9/19/2025, 8:00:01 PM
Fundamental Rating

2

Overall NOTV gets a fundamental rating of 2 out of 10. We evaluated NOTV against 55 industry peers in the Life Sciences Tools & Services industry. NOTV may be in some trouble as it scores bad on both profitability and health. NOTV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NOTV had negative earnings in the past year.
In the past year NOTV has reported a negative cash flow from operations.
NOTV had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: NOTV reported negative operating cash flow in multiple years.
NOTV Yearly Net Income VS EBIT VS OCF VS FCFNOTV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

With a Return On Assets value of -10.39%, NOTV perfoms like the industry average, outperforming 47.27% of the companies in the same industry.
The Return On Equity of NOTV (-54.92%) is worse than 70.91% of its industry peers.
Industry RankSector Rank
ROA -10.39%
ROE -54.92%
ROIC N/A
ROA(3y)-20.38%
ROA(5y)-13.08%
ROE(3y)-65.39%
ROE(5y)-49.53%
ROIC(3y)N/A
ROIC(5y)N/A
NOTV Yearly ROA, ROE, ROICNOTV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

NOTV's Gross Margin of 23.33% is on the low side compared to the rest of the industry. NOTV is outperformed by 81.82% of its industry peers.
NOTV's Gross Margin has declined in the last couple of years.
NOTV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.4%
GM growth 5Y-6.74%
NOTV Yearly Profit, Operating, Gross MarginsNOTV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

0

2. Health

2.1 Basic Checks

NOTV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NOTV has been increased compared to 1 year ago.
The number of shares outstanding for NOTV has been increased compared to 5 years ago.
Compared to 1 year ago, NOTV has a worse debt to assets ratio.
NOTV Yearly Shares OutstandingNOTV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NOTV Yearly Total Debt VS Total AssetsNOTV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -0.55, we must say that NOTV is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.55, NOTV is doing worse than 78.18% of the companies in the same industry.
A Debt/Equity ratio of 2.73 is on the high side and indicates that NOTV has dependencies on debt financing.
NOTV has a worse Debt to Equity ratio (2.73) than 90.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.73
Debt/FCF N/A
Altman-Z -0.55
ROIC/WACCN/A
WACC8.31%
NOTV Yearly LT Debt VS Equity VS FCFNOTV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

NOTV has a Current Ratio of 1.29. This is a normal value and indicates that NOTV is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.29, NOTV is not doing good in the industry: 83.64% of the companies in the same industry are doing better.
A Quick Ratio of 0.96 indicates that NOTV may have some problems paying its short term obligations.
With a Quick ratio value of 0.96, NOTV is not doing good in the industry: 83.64% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 0.96
NOTV Yearly Current Assets VS Current LiabilitesNOTV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

6

3. Growth

3.1 Past

NOTV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.69%, which is quite impressive.
Looking at the last year, NOTV shows a small growth in Revenue. The Revenue has grown by 0.85% in the last year.
The Revenue has been growing by 62.28% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)29.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49%
Revenue 1Y (TTM)0.85%
Revenue growth 3Y76.27%
Revenue growth 5Y62.28%
Sales Q2Q%23.54%

3.2 Future

The Earnings Per Share is expected to grow by 24.97% on average over the next years. This is a very strong growth
Based on estimates for the next years, NOTV will show a quite strong growth in Revenue. The Revenue will grow by 14.23% on average per year.
EPS Next Y43.04%
EPS Next 2Y24.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.5%
Revenue Next 2Y5.82%
Revenue Next 3Y17.67%
Revenue Next 5Y14.23%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
NOTV Yearly Revenue VS EstimatesNOTV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
NOTV Yearly EPS VS EstimatesNOTV Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 -1 -2 -3 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NOTV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NOTV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NOTV Price Earnings VS Forward Price EarningsNOTV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NOTV is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.58
NOTV Per share dataNOTV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

NOTV's earnings are expected to grow with 24.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.97%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NOTV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INOTIV INC

NASDAQ:NOTV (9/19/2025, 8:00:01 PM)

After market: 1.38 +0.01 (+0.73%)

1.37

-0.08 (-5.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)12-01 2025-12-01/amc
Inst Owners24.33%
Inst Owner Change16.53%
Ins Owners9.68%
Ins Owner Change-0.3%
Market Cap47.06M
Analysts80
Price Target5.61 (309.49%)
Short Float %7.05%
Short Ratio4.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.49%
Min EPS beat(2)2.91%
Max EPS beat(2)32.07%
EPS beat(4)3
Avg EPS beat(4)12.77%
Min EPS beat(4)-5.26%
Max EPS beat(4)32.07%
EPS beat(8)4
Avg EPS beat(8)-23.22%
EPS beat(12)7
Avg EPS beat(12)-12.32%
EPS beat(16)10
Avg EPS beat(16)95.16%
Revenue beat(2)1
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)0.84%
Revenue beat(4)2
Avg Revenue beat(4)1.24%
Min Revenue beat(4)-3.54%
Max Revenue beat(4)9.34%
Revenue beat(8)2
Avg Revenue beat(8)-2.76%
Revenue beat(12)5
Avg Revenue beat(12)-0.89%
Revenue beat(16)9
Avg Revenue beat(16)2.78%
PT rev (1m)0%
PT rev (3m)6.45%
EPS NQ rev (1m)-15%
EPS NQ rev (3m)-15%
EPS NY rev (1m)-2.86%
EPS NY rev (3m)3.9%
Revenue NQ rev (1m)0.61%
Revenue NQ rev (3m)-0.41%
Revenue NY rev (1m)0.61%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B 0.33
P/tB N/A
EV/EBITDA 27.58
EPS(TTM)-2.7
EYN/A
EPS(NY)-1.84
Fwd EYN/A
FCF(TTM)-1.35
FCFYN/A
OCF(TTM)-0.79
OCFYN/A
SpS14.71
BVpS4.19
TBVpS-5.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.39%
ROE -54.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.33%
FCFM N/A
ROA(3y)-20.38%
ROA(5y)-13.08%
ROE(3y)-65.39%
ROE(5y)-49.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.4%
GM growth 5Y-6.74%
F-Score4
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 2.73
Debt/FCF N/A
Debt/EBITDA 24.46
Cap/Depr 33.99%
Cap/Sales 3.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 0.96
Altman-Z -0.55
F-Score4
WACC8.31%
ROIC/WACCN/A
Cap/Depr(3y)54.31%
Cap/Depr(5y)102.83%
Cap/Sales(3y)5.33%
Cap/Sales(5y)8.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49%
EPS Next Y43.04%
EPS Next 2Y24.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.85%
Revenue growth 3Y76.27%
Revenue growth 5Y62.28%
Sales Q2Q%23.54%
Revenue Next Year6.5%
Revenue Next 2Y5.82%
Revenue Next 3Y17.67%
Revenue Next 5Y14.23%
EBIT growth 1Y-41.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year461.52%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-146.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-460.32%
OCF growth 3YN/A
OCF growth 5YN/A